Active	Status	Sponsor type	Region	Phase	Filter
54 Active 0 Inactive 54 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

54 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Özdemir, Özlem
NCT05976399: Manual Lymph Drainage in Individuals With Migraine	Completed	N/A	40	RoW	Connective Tissue Massage, Manual Lymph Drainage	Izmir Democracy University	Manual Lymphatic Drainage	10/20	02/21
NCT06777771: Effects of Reformer Pilates in Pregnant Women	Recruiting	N/A	30	RoW	Reformer pilates exercises	Izmir Democracy University	Pregnancy Related, Pelvic Floor Disorders, Pain, Back, Pain, Neck, Pregnancy, Abdominal	08/25	09/25
NCT05993650: Inspiratory Muscle Training in Chronic Venous Diseases	Completed	N/A	40	RoW	Inspiratuar Muscle Training Group, Inspiratuar Muscle Training, Thoracic Expansion Exercise Group	Izmir Democracy University	Chronic Venous Insufficiency	07/24	07/24
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
Şeber, Erdoğan Selçuk
NCT04765215: Investigation of the Effectiveness of CoronaVac Vaccine in Cancer Patients With Active Chemotherapy and Comparison With Healthy People.	Active, not recruiting	N/A	291	RoW	CoronoVAC	Asoc. Prof. Erdoğan Selçuk Şeber	Is the Coronovac Vaccine Effective in Patients Receiving Chemotherapy	07/21	03/22
NCT04992455: G8, VES-13 and CARG Scores in Predicting Chemotherapy Toxicity in Geriatric Cancer Patients	Active, not recruiting	N/A	150	RoW	Older Patients Receiving Chemotherapy	Namik Kemal University	Predicting Chemotherapy Related Toxicity in Elderly Patients	09/21	09/21
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
NCT05564923: CARG, VES13, G8 Scales in Predicting Drug Toxicity in Patients Receiving Nivolumab	Recruiting	N/A	100	RoW	there is no intervention	Namik Kemal University	Nivolumab Related Toxicity	06/23	08/23
TaÅŸkaynatan, Halil
NCT04765215: Investigation of the Effectiveness of CoronaVac Vaccine in Cancer Patients With Active Chemotherapy and Comparison With Healthy People.	Active, not recruiting	N/A	291	RoW	CoronoVAC	Asoc. Prof. Erdoğan Selçuk Şeber	Is the Coronovac Vaccine Effective in Patients Receiving Chemotherapy	07/21	03/22
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
Alan, Özkan
NCT04765215: Investigation of the Effectiveness of CoronaVac Vaccine in Cancer Patients With Active Chemotherapy and Comparison With Healthy People.	Active, not recruiting	N/A	291	RoW	CoronoVAC	Asoc. Prof. Erdoğan Selçuk Şeber	Is the Coronovac Vaccine Effective in Patients Receiving Chemotherapy	07/21	03/22
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
Avcı, Okan
NCT04765215: Investigation of the Effectiveness of CoronaVac Vaccine in Cancer Patients With Active Chemotherapy and Comparison With Healthy People.	Active, not recruiting	N/A	291	RoW	CoronoVAC	Asoc. Prof. Erdoğan Selçuk Şeber	Is the Coronovac Vaccine Effective in Patients Receiving Chemotherapy	07/21	03/22
NCT05564923: CARG, VES13, G8 Scales in Predicting Drug Toxicity in Patients Receiving Nivolumab	Recruiting	N/A	100	RoW	there is no intervention	Namik Kemal University	Nivolumab Related Toxicity	06/23	08/23
Çavdar, Eyyüp
NCT04765215: Investigation of the Effectiveness of CoronaVac Vaccine in Cancer Patients With Active Chemotherapy and Comparison With Healthy People.	Active, not recruiting	N/A	291	RoW	CoronoVAC	Asoc. Prof. Erdoğan Selçuk Şeber	Is the Coronovac Vaccine Effective in Patients Receiving Chemotherapy	07/21	03/22
NCT04992455: G8, VES-13 and CARG Scores in Predicting Chemotherapy Toxicity in Geriatric Cancer Patients	Active, not recruiting	N/A	150	RoW	Older Patients Receiving Chemotherapy	Namik Kemal University	Predicting Chemotherapy Related Toxicity in Elderly Patients	09/21	09/21
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
NCT05564923: CARG, VES13, G8 Scales in Predicting Drug Toxicity in Patients Receiving Nivolumab	Recruiting	N/A	100	RoW	there is no intervention	Namik Kemal University	Nivolumab Related Toxicity	06/23	08/23
Karaboyun, Kubilay
NCT04765215: Investigation of the Effectiveness of CoronaVac Vaccine in Cancer Patients With Active Chemotherapy and Comparison With Healthy People.	Active, not recruiting	N/A	291	RoW	CoronoVAC	Asoc. Prof. Erdoğan Selçuk Şeber	Is the Coronovac Vaccine Effective in Patients Receiving Chemotherapy	07/21	03/22
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
NEUROTOX, NCT05622617: Relationship Between Serum Interleukin-20 Level and Paclitaxel-associated Neuropathy	Recruiting	N/A	50	RoW	no intervention	Namik Kemal University	Neuropathy Associated With Dysproteinaemias	03/23	04/23
NCT05564923: CARG, VES13, G8 Scales in Predicting Drug Toxicity in Patients Receiving Nivolumab	Recruiting	N/A	100	RoW	there is no intervention	Namik Kemal University	Nivolumab Related Toxicity	06/23	08/23
İriağaç, Yakup
NCT04765215: Investigation of the Effectiveness of CoronaVac Vaccine in Cancer Patients With Active Chemotherapy and Comparison With Healthy People.	Active, not recruiting	N/A	291	RoW	CoronoVAC	Asoc. Prof. Erdoğan Selçuk Şeber	Is the Coronovac Vaccine Effective in Patients Receiving Chemotherapy	07/21	03/22
NCT05564923: CARG, VES13, G8 Scales in Predicting Drug Toxicity in Patients Receiving Nivolumab	Recruiting	N/A	100	RoW	there is no intervention	Namik Kemal University	Nivolumab Related Toxicity	06/23	08/23
Ocak, Birol
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
İsak, Özlem Aydın
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
Taşçı, Elif Şenocak
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
Tacar, Seher Yıldız
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
Ürün, Müslih
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
Türker, Sema
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
Kaçan, Turgut
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
Şimşek, Eda Tanrıkulu
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
Yıldırım, Hasan Çağrı
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
Åžakalar, Teoman
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
Deniz, Gülhan İpek
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
Ersoy, Mustafa
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
KarakaÅŸ, Yusuf
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
DeÄŸerli, Ezgi
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
Demir, Hacer
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
AkbaÅŸ, Sinem
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
Gülmez, Ahmet
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
Arıkan, Rukiye
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
Özer, Özden
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
Ön, Sercan
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
Koçak, Zahid
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
Mandel, Nil Molinas
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
EÅŸbah, Onur
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
Ä°nal, Ali
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
Araz, Murat
NCT06428422: The Impact of Probiotic on Survival and Treatment Response in Metastatic Non-small Cell Lung Cancer Patients	Recruiting	N/A	100	RoW	Bifidobacterium animalis subsp. lactis Bl-04, Plasebo	Necmettin Erbakan University, Health Institutes of Türkiye (TUSEB)	Metastatic Non-small Cell Lung Cancer	10/25	12/26
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
Sakin, Abdullah
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
AVCI, Okan
NCT05051956: Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?	Not yet recruiting	N/A	140	RoW	Palbociclib 125mg and Ribociclib 600 mg	Namik Kemal University	Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors	12/21	12/21
Erden, Dilek
NCT05967559: Online Flipped Learning in Nursing Student	Completed	N/A	68	RoW	Online Flipped Learning Group, Traditional learning Group	Namik Kemal University	Chemotherapy Effect	07/21	07/22
NCT06033443: Nursing Education and Collaborative Learning	Not yet recruiting	N/A	112	NA	Collaborative Learning Group	Namik Kemal University	Nursing Education	12/23	12/23